Submit a Review & Earn an Amazon Gift Card
You can now submit reviews for your favorite Tocris products. Your review will help other researchers decide on the best products for their research. Why not submit a review today?!
Submit ReviewKU14R is a antagonist of the atypical imidazoline binding site (putative I3 receptor) of pancreatic β-cells. Selectively blocks efaroxan-induced insulin secretion in vitro and in vivo.
分子量 | 214.27 |
公式 | C13H14N2O |
储存 | Store at RT |
纯度 | ≥99% (HPLC) |
CAS Number | 189224-48-4 |
PubChem ID | 4302964 |
InChI Key | JCWVNNMJXQJVNC-UHFFFAOYSA-N |
Smiles | CCC1(CC2=CC=CC=C2O1)C1=NC=CN1 |
上方提供的技术数据仅供参考。批次相关数据请参见分析证书。
Tocris products are intended for laboratory research use only, unless stated otherwise.
参考文献是支持产品生物活性的出版物。
Chan et al (1997) The putative endogenous imidazoline receptor ligand, clonidine-displacing substance, is a potent Ins secretagogue in rat and human islets of Langerhans. Br.J.Pharmacol. 120 926 PMID: 9138700
Chan et al (1997) Clotrimazole and efaroxan stimulate Ins secretion by different mechanisms in rat pancreatic islets. Naunyn Schmiedebergs Arch.Pharmacol. 356 763 PMID: 9453462
Mayer and Taberner (2002) Effects of the imidazoline ligands efaroxan and KU14R on blood glucose in the mouse. Eur.J.Pharmacol. 454 95 PMID: 12409010
关键词: KU14R, KU14R supplier, Antagonists, pancreatic, imidazoline, receptors, I3, Receptors, 1131, Tocris Bioscience
引用文献是使用了 Tocris 产品的出版物。 KU14R 的部分引用包括:
Mourtada et al (1999) Multiple effector pathways regulate the Ins secretory response to the imidazoline RX871024 in isolated rat pancreatic islets. Br J Pharmacol 127 1279 PMID: 10455276
目前没有该产品的评论。 Be the first to review KU14R and earn rewards!
$50/€35/£30/$50CAN/¥300 Yuan/¥5000 Yen for first to review with an image
$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image